These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 16268976)
1. The association of body mass index with Barrett's oesophagus. Stein DJ; El-Serag HB; Kuczynski J; Kramer JR; Sampliner RE Aliment Pharmacol Ther; 2005 Nov; 22(10):1005-10. PubMed ID: 16268976 [TBL] [Abstract][Full Text] [Related]
2. Leptin and the risk of Barrett's oesophagus. Kendall BJ; Macdonald GA; Hayward NK; Prins JB; Brown I; Walker N; Pandeya N; Green AC; Webb PM; Whiteman DC; Gut; 2008 Apr; 57(4):448-54. PubMed ID: 18178609 [TBL] [Abstract][Full Text] [Related]
3. The relationship between length of Barrett's oesophagus mucosa and body mass index. Abdallah J; Maradey-Romero C; Lewis S; Perzynski A; Fass R Aliment Pharmacol Ther; 2015 Jan; 41(1):137-44. PubMed ID: 25327893 [TBL] [Abstract][Full Text] [Related]
4. Body mass index and Barrett's oesophagus in women. Jacobson BC; Chan AT; Giovannucci EL; Fuchs CS Gut; 2009 Nov; 58(11):1460-6. PubMed ID: 19336423 [TBL] [Abstract][Full Text] [Related]
5. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance? Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485 [TBL] [Abstract][Full Text] [Related]
6. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors. Gerson LB; Boparai V; Ullah N; Triadafilopoulos G Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912 [TBL] [Abstract][Full Text] [Related]
7. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications. Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA; Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305 [TBL] [Abstract][Full Text] [Related]
8. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease? Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223 [TBL] [Abstract][Full Text] [Related]
9. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Kubo A; Cook MB; Shaheen NJ; Vaughan TL; Whiteman DC; Murray L; Corley DA Gut; 2013 Dec; 62(12):1684-91. PubMed ID: 23355549 [TBL] [Abstract][Full Text] [Related]
10. Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Chak A; Lee T; Kinnard MF; Brock W; Faulx A; Willis J; Cooper GS; Sivak MV; Goddard KA Gut; 2002 Sep; 51(3):323-8. PubMed ID: 12171951 [TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus. Koek GH; Sifrim D; Lerut T; Janssens J; Tack J Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496 [TBL] [Abstract][Full Text] [Related]
12. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy. El-Serag HB; Aguirre T; Kuebeler M; Sampliner RE Aliment Pharmacol Ther; 2004 Jun; 19(12):1255-60. PubMed ID: 15191506 [TBL] [Abstract][Full Text] [Related]
13. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128 [TBL] [Abstract][Full Text] [Related]
14. Association between the body mass index and the risk of Barrett's esophagus in Japan. Shinkai H; Iijima K; Koike T; Abe Y; Dairaku N; Inomata Y; Kayaba S; Ishiyama F; Oikawa T; Ohyauchi M; Ito H; Asonuma S; Hoshi T; Kato K; Ohara S; Shimosegawa T Digestion; 2014; 90(1):1-9. PubMed ID: 25074386 [TBL] [Abstract][Full Text] [Related]
15. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma. Tsibouris P; Hendrickse MT; Isaacs PE Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913 [TBL] [Abstract][Full Text] [Related]
16. Statin use is associated with a decreased risk of Barrett's esophagus. Nguyen T; Khalaf N; Ramsey D; El-Serag HB Gastroenterology; 2014 Aug; 147(2):314-23. PubMed ID: 24798416 [TBL] [Abstract][Full Text] [Related]
17. Association of adiponectin multimers with Barrett's oesophagus. Rubenstein JH; Kao JY; Madanick RD; Zhang M; Wang M; Spacek MB; Donovan JL; Bright SD; Shaheen NJ Gut; 2009 Dec; 58(12):1583-9. PubMed ID: 19570765 [TBL] [Abstract][Full Text] [Related]
18. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313 [TBL] [Abstract][Full Text] [Related]
19. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568 [TBL] [Abstract][Full Text] [Related]
20. Alcohol consumption pattern and risk of Barrett's oesophagus and erosive oesophagitis: an Italian case-control study. Filiberti RA; Fontana V; De Ceglie A; Blanchi S; Grossi E; Della Casa D; Lacchin T; De Matthaeis M; Ignomirelli O; Cappiello R; Rosa A; Foti M; Laterza F; D'Onofrio V; Iaquinto G; Conio M Br J Nutr; 2017 Apr; 117(8):1151-1161. PubMed ID: 28478792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]